Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.35 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | XBP1 | P17861 | 1/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2135110 | 1.00 | NPC1 (0.35) | NPC1S1PR2S1PR4ALDH1A1LMNA | |
| SCHEMBL776640 | 0.97 | NPC1 (0.36) | NPC1S1PR2S1PR4ALDH1A1LMNA | |
| SCHEMBL1283388 | 0.90 | NPC1 (0.36) | NPC1S1PR2S1PR4ALDH1A1LMNA | |
| SCHEMBL10639166 | 0.87 | FAAH (0.50) | NPC1S1PR2S1PR4ALDH1A1LMNA | |
| SCHEMBL11336707 | 0.87 | FAAH (0.50) | NPC1S1PR2S1PR4ALDH1A1LMNA | |
| SCHEMBL22894669 | 0.87 | FAAH (0.50) | NPC1S1PR2S1PR4ALDH1A1LMNA | |
| SCHEMBL11325650 | 0.87 | FAAH (0.50) | NPC1S1PR2S1PR4ALDH1A1LMNA | |
| SCHEMBL11333957 | 0.87 | FAAH (0.50) | NPC1S1PR2S1PR4ALDH1A1LMNA | |
| SCHEMBL7756252 | 0.86 | NPC1 (0.31) | NPC1S1PR2S1PR4ALDH1A1LMNA | |
| SCHEMBL27451940 | 0.85 | TSHR (0.41) | FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170028075-A1 | INJECTABLE DENDRIMER HYDROGEL NANOPARTICLES | Ashvattha Therapeutics, Inc. | 2017-02-02 | — | — | US | disclosed |
| US-20170028075-A1 | INJECTABLE DENDRIMER HYDROGEL NANOPARTICLES | Ashvattha Therapeutics, Inc. | 2017-02-02 | — | — | US | disclosed |
| US-9526794-B2 | Injectable dendrimer hydrogel nanoparticles | WAYNE STATE UNIVERSITY (US) | 2016-12-27 | — | — | US | disclosed |
| US-9526794-B2 | Injectable dendrimer hydrogel nanoparticles | WAYNE STATE UNIVERSITY (US) | 2016-12-27 | — | — | US | disclosed |
| US-20160311934-A1 | HYDROXYALKYL STARCH DERIVATIVES AS REACTANTS FOR COUPLING TO THIOL GROUPS | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2016-10-27 | — | — | US | disclosed |
| US-20160311934-A1 | HYDROXYALKYL STARCH DERIVATIVES AS REACTANTS FOR COUPLING TO THIOL GROUPS | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2016-10-27 | — | — | US | disclosed |
| EP-2635442-B1 | TRANSPARENT INK-JET RECORDING FILMS | CARESTREAM HEALTH INC (US) | 2015-11-25 | — | — | EP | disclosed |
| EP-2629981-B1 | TRANSPARENT INK- JET RECORDING FILMS | CARESTREAM HEALTH INC (US) | 2015-08-05 | — | — | EP | disclosed |
| US-8895965-B2 | Photoelectric conversion element, production method for a photoelectric conversion element, solid-state image sensor, production method for a solid-state image sensor, electronic apparatus, photoconductor, production method for a photoconductor and multilayer transparent photoelectric conversion element | SONY CORPORATION (JP) | 2014-11-25 | — | — | US | disclosed |
| US-8895965-B2 | Photoelectric conversion element, production method for a photoelectric conversion element, solid-state image sensor, production method for a solid-state image sensor, electronic apparatus, photoconductor, production method for a photoconductor and multilayer transparent photoelectric conversion element | SONY CORPORATION (JP) | 2014-11-25 | — | — | US | disclosed |
| WO-2012058347-A1 | TRANSPARENT INK-JET RECORDING FILMS, COMPOSITIONS, AND METHODS | CARESTREAM HEALTH, INC. (US) | 2012-05-03 | — | — | WO | disclosed |
| US-20120107528-A1 | TRANSPARENT INK-JET RECORDING FILMS, COMPOSITIONS, AND METHODS | QUANTUM MEDICAL IMAGING, L.L.C. | 2012-05-03 | — | — | US | disclosed |
| WO-2012058354-A1 | TRANSPARENT INK-JET RECORDING FILMS, COMPOSITIONS, AND METHODS | CARESTREAM HEALTH, INC. (US) | 2012-05-03 | — | — | WO | disclosed |
| US-20120107532-A1 | TRANSPARENT INK-JET RECORDING FILMS, COMPOSITIONS, AND METHODS | CARESTREAM DENTAL LLC | 2012-05-03 | — | — | US | disclosed |
| US-20120107529-A1 | TRANSPARENT INK-JET RECORDING FILMS, COMPOSITIONS, AND METHODS | QUANTUM MEDICAL IMAGING, L.L.C. | 2012-05-03 | — | — | US | disclosed |
| US-20120100315-A1 | TRANSPARENT INK-JET RECORDING FILMS, COMPOSITIONS, AND METHODS | CARESTREAM DENTAL LLC | 2012-04-26 | — | — | US | disclosed |
| US-20100092872-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY USING THE SAME | UBE INDUSTRIES, LTD. (JP) | 2010-04-15 | — | — | US | disclosed |
| EP-2138481-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY USING THE SAME | Ube Industries, Ltd. (JP) | 2009-12-30 | — | — | EP | disclosed |
| US-7589070-B2 | Surface modification for improving biocompatibility | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2009-09-15 | — | — | US | disclosed |
| US-RE29305-E | HARDENABLE HYDROPHILIC COLLOIDS, PHOTOGRAPHY | EASTMAN KODAK COMPANY (US) | 1977-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160311934-A1 | HYDROXYALKYL STARCH DERIVATIVES AS REACTANTS FOR COUPLING TO THIOL GROUPS | MSR1, C3AR1, C1R | NPC1 3961/4885S1PR2 562/4885S1PR4 971/4885 |
| US-20170028075-A1 | INJECTABLE DENDRIMER HYDROGEL NANOPARTICLES | PAM, UACA, FLT1 | NPC1 4774/4885S1PR2 2372/4885S1PR4 2137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.